CorFlow Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 41

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $48.7M

  • Investors
  • 13

CorFlow General Information

Description

Developer of a diagnostic and therapeutic medical device designed to improve the quality of human life with a relentless pursuit to solve unmet medical needs. The company's controlled flow infusion system measures the degree of microvascular obstruction using a proprietary and dynamic microvascular resistance concept and compares these peri-procedural dMVR values to post-procedure contrast-enhanced magnetic resonance imaging, enabling interventional cardiologists to diagnose and treat microvascular obstruction in severe heart attack patients.

Contact Information

Website
www.corflow.com
Formerly Known As
ReFlow Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Neuhofstrasse 3d
  • 6340 Baar
  • Switzerland
+41 041
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Vertical(s)
LOHAS & Wellness, HealthTech
Corporate Office
  • Neuhofstrasse 3d
  • 6340 Baar
  • Switzerland
+41 041

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CorFlow Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 09-Sep-2024 $48.7M Completed Clinical Trials - General
6. Later Stage VC (Series A) 31-Mar-2021 Completed Clinical Trials - General
5. Grant 30-Nov-2018 Completed Pre-Clinical Trials
4. Seed Round 17-Aug-2018 Completed Pre-Clinical Trials
3. Seed Round 17-Nov-2017 Completed Pre-Clinical Trials
2. Grant 31-Jan-2017 $819K $2.57M Completed Pre-Clinical Trials
1. Seed Round 08-Sep-2016 $2.57M $2.57M Completed Startup
To view CorFlow’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

CorFlow Patents

  • 83

    Total Documents Applications and Grants

  • Total Patents Families

  • 55

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

CorFlow Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022206116-A1 Apparatus and method for determining and/or treating microvascular obstruction Pending 11-Jan-2021
CA-3204169-A1 Apparatus and method for determining and/or treating microvascular obstruction Pending 11-Jan-2021
EP-4274471-A1 Apparatus and method for determining and/or treating microvascular obstruction Active 11-Jan-2021
EP-4274471-B1 Apparatus and method for determining and/or treating microvascular obstruction Active 11-Jan-2021
EP-4274471-B8 Apparatus and method for determining and/or treating microvascular obstruction Active 11-Jan-2021 A61B5/026
To view CorFlow’s complete patent history, request access »

CorFlow Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CorFlow Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
Broadview Ventures Venture Capital Minority
KOFA Healthcare Venture Capital Minority
Korys Investments Family Office Minority
Laerdal Million Lives Fund Impact Investing Minority
Merieux Equity Partners (Lyon) PE/Buyout Minority
You’re viewing 5 of 13 investors. Get the full list »

Ready to get started?

Request a free trial

CorFlow FAQs

  • When was CorFlow founded?

    CorFlow was founded in 2016.

  • Where is CorFlow headquartered?

    CorFlow is headquartered in Baar, Switzerland.

  • What is the size of CorFlow?

    CorFlow has 41 total employees.

  • What industry is CorFlow in?

    CorFlow’s primary industry is Diagnostic Equipment.

  • Is CorFlow a private or public company?

    CorFlow is a Private company.

  • What is CorFlow’s current revenue?

    The current revenue for CorFlow is .

  • How much funding has CorFlow raised over time?

    CorFlow has raised $73.9M.

  • Who are CorFlow’s investors?

    Broadview Ventures, KOFA Healthcare, Korys Investments, Laerdal Million Lives Fund, and Merieux Equity Partners (Lyon) are 5 of 13 investors who have invested in CorFlow.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process